Alzamend Neuro, Inc. (ALZN) stock
ALZNNasdaqPharmaceutical PreparationsFiscal year ends April 30
$1.04−0.09 (-7.96%)
Close on Nov 18, 2026Market cap $5.02MP/E –Yield –
Alzamend Neuro cash
Cash and short-term investments held at the end of each period.
Alzamend Neuro's cash was $7.59M at Jul 31, 2026. For fiscal 2026 it was $710.69K, down 82.0% from the year before. The highest annual figure on record is $14.06M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 30, 2026 | $710.69K | -82.0% |
| FY2025 | Apr 30, 2025 | $3.95M | +950.0% |
| FY2024 | Apr 30, 2024 | $376.05K | -92.7% |
| FY2023 | Apr 30, 2023 | $5.14M | -63.4% |
| FY2022 | Apr 30, 2022 | $14.06M | +629.0% |
| FY2021 | Apr 30, 2021 | $1.93M | +2036.9% |
| FY2020 | Apr 30, 2020 | $90.29K | +111.9% |
| FY2019 | Apr 30, 2019 | $42.61K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | $7.59M | +35.1% |
| Q4 FY2026CQ1 2026 | Apr 30, 2026 | $710.69K | -82.0% |
| Q3 FY2026CQ4 2025 | Jan 31, 2026 | $2.71M | +127.2% |
| Q2 FY2026CQ3 2025 | Oct 31, 2025 | $4.45M | +1083.2% |
| Q1 FY2026CQ2 2025 | Jul 31, 2025 | $5.62M | +1887.1% |
| Q4 FY2025CQ1 2025 | Apr 30, 2025 | $3.95M | +1873.5% |
| Q1 FY2025CQ2 2024 | Jul 31, 2024 | $1.19M | -29.6% |
| Q4 FY2024CQ1 2024 | Apr 30, 2024 | $376.05K | -92.7% |
| Q3 FY2024CQ4 2023 | Jan 31, 2024 | $282.87K | -96.2% |
| Q2 FY2024CQ3 2023 | Oct 31, 2023 | $200.08K | -97.8% |
| Q1 FY2024CQ2 2023 | Jul 31, 2023 | $1.70M | -85.3% |
| Q4 FY2023CQ1 2023 | Apr 30, 2023 | $5.14M | -63.4% |
| Q3 FY2023CQ4 2022 | Jan 31, 2023 | $7.38M | -37.4% |
| Q2 FY2023CQ3 2022 | Oct 31, 2022 | $9.18M | -32.3% |
| Q1 FY2023CQ2 2022 | Jul 31, 2022 | $11.53M | -26.2% |
| Q4 FY2022CQ1 2022 | Apr 30, 2022 | $14.06M | +629.0% |
| Q3 FY2022CQ4 2021 | Jan 31, 2022 | $11.79M | +28842.5% |
| Q2 FY2022CQ3 2021 | Oct 31, 2021 | $13.57M | +231515.9% |
| Q1 FY2022CQ2 2021 | Jul 31, 2021 | $15.62M | +24646.0% |
| Q4 FY2021CQ1 2021 | Apr 30, 2021 | $1.93M | +2036.9% |
| Q3 FY2021CQ4 2020 | Jan 31, 2021 | $40.74K | -4.4% |
| Q2 FY2021CQ3 2020 | Oct 31, 2020 | $5.86K | – |
| Q1 FY2021CQ2 2020 | Jul 31, 2020 | $63.11K | – |
| Q4 FY2020CQ1 2020 | Apr 30, 2020 | $90.29K | – |
| Q4 FY2019CQ1 2019 | Apr 30, 2019 | $42.61K | – |
See a number that looks wrong?